目的:探究中小剂量倍他乐克 胺碘酮的治疗方案应用在室性心律失常治疗中的效果评价。方法:84 例室性心律失常患者以对照组和实验组区分,每组 42 例,对比两组治疗效果、再住院情况、心脏收缩功能、心电图检查值及安全性。结果:实验组治...目的:探究中小剂量倍他乐克 胺碘酮的治疗方案应用在室性心律失常治疗中的效果评价。方法:84 例室性心律失常患者以对照组和实验组区分,每组 42 例,对比两组治疗效果、再住院情况、心脏收缩功能、心电图检查值及安全性。结果:实验组治疗有效率、LVEF、QT 间期、QT 离散度、再住院率、不良反应发生率均优于对照组各项指标数据,P < 0.05。结论:胺碘酮 中小剂量倍他乐克对于提高患室性心律失常的临床疗效,改善患者相关症状,维持患者正常窦性心律具有积极的作用,同时药物造成的不良反应较轻,能够有效保证患者对药物的耐受性,实现安全有效的治疗。Abstract:Objective: To explore the effect evaluation of the treatment regimen of small and medium doses of betaloc amiodarone in the treatment of ventricular arrhythmia. Methods: Eighty-four patients with ventricular arrhythmias were divided into control group and experimental group, 42 cases in each group. The treatment effect, rehospitalization, cardiac systolic function, ECG value and safety were compared between the two groups. Results: The treatment effective rate, LVEF, QT interval, QT dispersion, rehospitalization rate, and incidence of adverse reactions in the experimental group were better than those in the control group, P<0.05. Conclusion: Amiodarone small and medium doses of betaloc have a positive effect on improving the clinical efficacy of patients with ventricular arrhythmia, improving the symptoms of patients, and maintaining normal sinus rhythm in patients. At the same time, the adverse reactions caused by the drug are mild and can effectively To ensure the tolerance of patients to drugs, to achieve safe and effective treatment.展开更多
文摘目的:探究中小剂量倍他乐克 胺碘酮的治疗方案应用在室性心律失常治疗中的效果评价。方法:84 例室性心律失常患者以对照组和实验组区分,每组 42 例,对比两组治疗效果、再住院情况、心脏收缩功能、心电图检查值及安全性。结果:实验组治疗有效率、LVEF、QT 间期、QT 离散度、再住院率、不良反应发生率均优于对照组各项指标数据,P < 0.05。结论:胺碘酮 中小剂量倍他乐克对于提高患室性心律失常的临床疗效,改善患者相关症状,维持患者正常窦性心律具有积极的作用,同时药物造成的不良反应较轻,能够有效保证患者对药物的耐受性,实现安全有效的治疗。Abstract:Objective: To explore the effect evaluation of the treatment regimen of small and medium doses of betaloc amiodarone in the treatment of ventricular arrhythmia. Methods: Eighty-four patients with ventricular arrhythmias were divided into control group and experimental group, 42 cases in each group. The treatment effect, rehospitalization, cardiac systolic function, ECG value and safety were compared between the two groups. Results: The treatment effective rate, LVEF, QT interval, QT dispersion, rehospitalization rate, and incidence of adverse reactions in the experimental group were better than those in the control group, P<0.05. Conclusion: Amiodarone small and medium doses of betaloc have a positive effect on improving the clinical efficacy of patients with ventricular arrhythmia, improving the symptoms of patients, and maintaining normal sinus rhythm in patients. At the same time, the adverse reactions caused by the drug are mild and can effectively To ensure the tolerance of patients to drugs, to achieve safe and effective treatment.
